Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Angiotensin II receptor blockers"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 43
Tytuł:
The impact of Renin-Angiotensin System Inhibitors on bone fracture risk: a nationwide nested case-control study.
Autorzy:
Kim KM; Department of Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, South Korea.
Hwang EJ; College of Pharmacy and Research Institute for Drug Development, Pusan National University, 2, Busandaehak-Ro, 63 Beon-Gil, Geumjeong-Gu, 46241, Busan, South Korea.
Lee S; Department of Statistics, College of Natural Science, Pusan National University, Busan, South Korea.
Yoon JH; College of Pharmacy and Research Institute for Drug Development, Pusan National University, 2, Busandaehak-Ro, 63 Beon-Gil, Geumjeong-Gu, 46241, Busan, South Korea. .
Pokaż więcej
Źródło:
BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2024 Jan 02; Vol. 25 (1), pp. 3. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Angiotensin-Converting Enzyme Inhibitors*/therapeutic use
Osteoporotic Fractures*/chemically induced
Osteoporotic Fractures*/epidemiology
Osteoporotic Fractures*/prevention & control
Humans ; Aged ; Renin-Angiotensin System ; Angiotensin Receptor Antagonists/adverse effects ; Case-Control Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Existence of Quantum Pharmacology in Sartans: Evidence in Isolated Rabbit Iliac Arteries.
Autorzy:
Gadanec LK; Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.
Swiderski J; Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.
Apostolopoulos V; Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.; Immunology Program, Australian Institute for Musculoskeletal Science (AIMSS), Melbourne, VIC 3021, Australia.
Kelaidonis K; NewDrug PC, Patras Science Park, 26 504 Patras, Greece.
Vidali VP; Institute of Nanoscience and Nanotechnology, National Centre for Scientific Research 'Demokritos', Ag. Paraskevi, 153 41 Athens, Greece.
Canko A; Institute of Nanoscience and Nanotechnology, National Centre for Scientific Research 'Demokritos', Ag. Paraskevi, 153 41 Athens, Greece.
Moore GJ; Pepmetics Inc., 772 Murphy Place, Victoria, BC V6Y 3H4, Canada.; Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Matsoukas JM; Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.; NewDrug PC, Patras Science Park, 26 504 Patras, Greece.; Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.; Department of Chemistry, University of Patras, 265 04 Patras, Greece.
Zulli A; Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 16; Vol. 24 (24). Date of Electronic Publication: 2023 Dec 16.
Typ publikacji:
Journal Article
MeSH Terms:
Angiotensin II Type 1 Receptor Blockers*/therapeutic use
Hypertension*/drug therapy
Rabbits ; Male ; Animals ; Telmisartan/pharmacology ; Angiotensin-Converting Enzyme 2/pharmacology ; Angiotensin Receptor Antagonists/pharmacology ; Iliac Artery ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Benzimidazoles/therapeutic use ; Tetrazoles/pharmacology ; Tetrazoles/therapeutic use ; Blood Pressure
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Expanding options of supportive care in IgA nephropathy.
Autorzy:
Maixnerova D; Department of Nephrology, General University Hospital, First Faculty of Medicine, Prague, Czech Republic.
Hartinger J; Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital Prague, Prague, Czech Republic.
Tesar V; Department of Nephrology, General University Hospital, First Faculty of Medicine, Prague, Czech Republic.
Pokaż więcej
Źródło:
Clinical kidney journal [Clin Kidney J] 2023 Dec 04; Vol. 16 (Suppl 2), pp. ii47-ii54. Date of Electronic Publication: 2023 Dec 04 (Print Publication: 2023).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pharmacological Nephroprotection in Non-Diabetic Chronic Kidney Disease-Clinical Practice Position Statement of the Polish Society of Nephrology.
Autorzy:
Stompór T; Department of Nephrology, Hypertension and Internal Medicine, University of Warmia and Mazury in Olsztyn, 10-516 Olsztyn, Poland.
Adamczak M; Department of Nephrology, Transplantation and Internal Medicine, Medical University of Silesia, 40-027 Katowice, Poland.
Kurnatowska I; Department of Internal Diseases and Transplant Nephrology, Medical University of Lodz, 90-419 Lodz, Poland.
Naumnik B; Ist Department of Nephrology and Transplantation with Dialysis Unit, Medical University of Bialystok, Zurawia 14 St., 15-540 Bialystok, Poland.
Nowicki M; Department of Nephrology, Hypertension and Kidney Transplantation, Central University Hospital, Medical University of Lodz, 92-213 Lodz, Poland.
Tylicki L; Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, 80-952 Gdansk, Poland.
Winiarska A; Department of Nephrology, Hypertension and Internal Medicine, University of Warmia and Mazury in Olsztyn, 10-516 Olsztyn, Poland.
Krajewska M; Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2023 Aug 09; Vol. 12 (16). Date of Electronic Publication: 2023 Aug 09.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers' Case-Control Study.
Autorzy:
García-Lluch G; Research Group in Alzheimer Disease, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.; Cátedra DeCo MICOF-CEU UCH, Universidad Cardenal Herrera-CEU, 46115 Valencia, Spain.
Peña-Bautista C; Research Group in Alzheimer Disease, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.
Royo LM; Cátedra DeCo MICOF-CEU UCH, Universidad Cardenal Herrera-CEU, 46115 Valencia, Spain.; Department of Pharmacy, Universidad Cardenal Herrera-CEU, CEU Universities, 46115 Valencia, Spain.
Baquero M; Research Group in Alzheimer Disease, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.; Cátedra DeCo MICOF-CEU UCH, Universidad Cardenal Herrera-CEU, 46115 Valencia, Spain.; Neurology Unit, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.
Cañada-Martínez AJ; Data Science and Biostatistics Unit, Health Research Institute La Fe, 46026 Valencia, Spain.
Cháfer-Pericás C; Research Group in Alzheimer Disease, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.; Cátedra DeCo MICOF-CEU UCH, Universidad Cardenal Herrera-CEU, 46115 Valencia, Spain.
Pokaż więcej
Źródło:
Pharmaceutics [Pharmaceutics] 2023 Mar 12; Vol. 15 (3). Date of Electronic Publication: 2023 Mar 12.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System.
Autorzy:
Moore GJ; Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.; Pepmetics Inc., 772 Murphy Place, Victoria, BC V8Y 3H4, Canada.
Ridgway H; Institute for Sustainable Industries and Liveable Cities, Victoria University, Melbourne, VIC 8001, Australia.; AquaMem Consultants, Rodeo, New Mexico, NM 88056, USA.
Kelaidonis K; NewDrug PC, Patras Science Park, 26504 Patras, Greece.
Chasapis CT; NMR Facility, Instrumental Analysis Laboratory, School of Natural Sciences, University of Patras, 26504 Patras, Greece.; Institute of Chemical Engineering Sciences, Foundation for Research and Technology, Hellas (FORTH/ICE-HT), 26504 Patras, Greece.
Ligielli I; Department of Chemistry, National and Kapodistrian University of Athens, 15784 Athens, Greece.
Mavromoustakos T; Department of Chemistry, National and Kapodistrian University of Athens, 15784 Athens, Greece.
Bojarska J; Institute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, Zeromskiego 116, 90-924 Lodz, Poland.
Matsoukas JM; Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.; NewDrug PC, Patras Science Park, 26504 Patras, Greece.; Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2022 Jul 29; Vol. 27 (15). Date of Electronic Publication: 2022 Jul 29.
Typ publikacji:
Journal Article
MeSH Terms:
Hypertension*/drug therapy
COVID-19 Drug Treatment*
Angiotensin Receptor Antagonists/pharmacology ; Angiotensin Receptor Antagonists/therapeutic use ; Angiotensin-Converting Enzyme 2 ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Humans ; Neprilysin/metabolism ; Peptidyl-Dipeptidase A/metabolism ; Proto-Oncogene Mas ; Receptors, Angiotensin/metabolism ; Renin-Angiotensin System ; SARS-CoV-2 ; Zinc/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Diarrhea and angiotensin II receptor blockers: Is there any difference between the different drugs?
Autorzy:
Guion-Firmin J; Service de Pharmacologie Médicale et Clinique, Centre de Pharmacovigilance, de Pharmacoépidemiologie et d'Informations sur le Médicament, CIC INSERM 1436, Centre Hospitalier Universitaire-Faculté de Médecine, Toulouse, France.
Tessier S; Service de Pharmacologie Médicale et Clinique, Centre de Pharmacovigilance, de Pharmacoépidemiologie et d'Informations sur le Médicament, CIC INSERM 1436, Centre Hospitalier Universitaire-Faculté de Médecine, Toulouse, France.
Montastruc JL; Service de Pharmacologie Médicale et Clinique, Centre de Pharmacovigilance, de Pharmacoépidemiologie et d'Informations sur le Médicament, CIC INSERM 1436, Centre Hospitalier Universitaire-Faculté de Médecine, Toulouse, France.
Pokaż więcej
Źródło:
Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2022 Apr; Vol. 36 (2), pp. 443-447. Date of Electronic Publication: 2021 Dec 02.
Typ publikacji:
Journal Article
MeSH Terms:
Angiotensin Receptor Antagonists*/adverse effects
Diarrhea*/chemically induced
Hypertension*/drug therapy
Aged ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Antihypertensive Agents/adverse effects ; Female ; Humans ; Telmisartan/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Immunomodulatory Activity of the Most Commonly Used Antihypertensive Drugs-Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers.
Autorzy:
Bryniarski P; Department of Immunology, Jagiellonian University Medical College, 18 Czysta Street, 31-121 Krakow, Poland.
Nazimek K; Department of Immunology, Jagiellonian University Medical College, 18 Czysta Street, 31-121 Krakow, Poland.
Marcinkiewicz J; Department of Immunology, Jagiellonian University Medical College, 18 Czysta Street, 31-121 Krakow, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Feb 04; Vol. 23 (3). Date of Electronic Publication: 2022 Feb 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Angiotensin Receptor Antagonists/*pharmacology
Angiotensin-Converting Enzyme Inhibitors/*pharmacology
Immunomodulation/*drug effects
Animals ; Antihypertensive Agents/pharmacology ; COVID-19 ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pharmacokinetics and Safety of a Single Dose and Multiple Doses of Allisartan Isoproxil, an Angiotensin II Receptor Blocker, in Healthy Chinese People.
Autorzy:
Yi W; Department of Clinical Medicine, Medical College of Soochow University, Suzhou, China.; Phase I Clinical Research Center, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Yan P; Medical Oncology Wang jiang shan Inpatient Area, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Lin S; Phase I Clinical Research Center, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Hao R; Phase I Clinical Research Center, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Wang Y; Phase I Clinical Research Center, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Yu J; Phase I Clinical Research Center, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Fang L; Phase I Clinical Research Center, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Zhu J; Phase I Clinical Research Center, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Zhao D; Phase I Clinical Research Center, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Tong S; Phase I Clinical Research Center, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Si Y; Phase I Clinical Research Center, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Ye T; Phase I Clinical Research Center, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Wu Z; Phase I Clinical Research Center, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Qin Z; Medical Oncology Wang jiang shan Inpatient Area, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Huang H; Shenzhen Salubris Pharmaceuticals Co., Ltd, Shenzhen, China.
Deng C; Shenzhen Salubris Pharmaceuticals Co., Ltd, Shenzhen, China.
Sun J; Shenzhen Salubris Pharmaceuticals Co., Ltd, Shenzhen, China.
Wang Y; Phase I Clinical Research Center, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.; Clinical Research Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Pokaż więcej
Źródło:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2022 Jan; Vol. 11 (1), pp. 43-50. Date of Electronic Publication: 2021 Jul 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Angiotensin Receptor Antagonists*/adverse effects
Biphenyl Compounds*/adverse effects
Area Under Curve ; China ; Female ; Humans ; Imidazoles ; Male
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effect of Soluplus on γ-cyclodextrin solubilization of irbesartan and candesartan and their nanoaggregates formation.
Autorzy:
Soe HMSH; Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
Sripetch S; Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland.
Loftsson T; Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland.
Stefánsson E; Department of Ophthalmology, Faculty of Medicine, National University Hospital, University of Iceland, Reykjavik, Iceland.
Jansook P; Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
Pokaż więcej
Źródło:
Pharmaceutical development and technology [Pharm Dev Technol] 2022 Jan; Vol. 27 (1), pp. 9-18. Date of Electronic Publication: 2021 Dec 20.
Typ publikacji:
Journal Article
MeSH Terms:
gamma-Cyclodextrins*/chemistry
Benzimidazoles ; Biphenyl Compounds ; Calorimetry, Differential Scanning ; Irbesartan ; Polyethylene Glycols ; Polyvinyls ; Solubility ; Spectroscopy, Fourier Transform Infrared/methods ; Tetrazoles ; X-Ray Diffraction
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Determination of candesartan or olmesartan in hypertensive patient plasma using UPLC-MS/MS.
Autorzy:
Jeong HC; College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Korea.
Seo YH; College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Korea.
Gu N; Department of Clinical Pharmacology and Therapeutics, Dongguk University College of Medicine and Dongguk University Ilsan Hospital, Goyang 10326, Korea.
Rhee MY; Cardiovascular Center, Dongguk University Ilsan Hospital, Goyang 10326, Korea.
Shin KH; College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Korea.
Pokaż więcej
Źródło:
Translational and clinical pharmacology [Transl Clin Pharmacol] 2021 Dec; Vol. 29 (4), pp. 226-238. Date of Electronic Publication: 2021 Dec 16.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Renin-angiotensin system in intestinal inflammation-Angiotensin inhibitors to treat inflammatory bowel diseases?
Autorzy:
Salmenkari H; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Korpela R; Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Research Program for Human Microbiome, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Vapaatalo H; Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Pokaż więcej
Źródło:
Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2021 Sep; Vol. 129 (3), pp. 161-172. Date of Electronic Publication: 2021 Jun 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Angiotensins/*antagonists & inhibitors
Inflammation/*drug therapy
Inflammatory Bowel Diseases/*drug therapy
Renin-Angiotensin System/*drug effects
Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Angiotensins/pharmacology ; Angiotensins/therapeutic use ; Animals ; Antihypertensive Agents/therapeutic use ; Colitis/drug therapy ; Drug Evaluation, Preclinical ; Fibrosis ; Humans ; Hypertension/drug therapy ; Inflammatory Bowel Diseases/complications ; Mice ; Models, Animal ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Angiotensin axis antagonists increase the incidence of haemodynamic instability in dihydropyridine calcium channel blocker poisoning.
Autorzy:
Huang J; Faculty of Medicine, University of New South Wales, Sydney, Australia.
Buckley NA; Faculty of Medicine and Health, University of Sydney, Sydney, Australia.; New South Wales Poisons Information Centre, The Children's Hospital at Westmead, Westmead, Australia.
Isoardi KZ; Clinical Toxicology Unit, Princess Alexandra Hospital, Woolloongabba, Australia.
Chiew AL; Faculty of Medicine, University of New South Wales, Sydney, Australia.; Clinical Toxicology Unit, Prince of Wales Hospital, Randwick, Australia.
Isbister GK; Department of Clinical Toxicology and Pharmacology, Calvary Mater Hospital, Waratah, Australia.
Cairns R; Faculty of Medicine and Health, University of Sydney, Sydney, Australia.; New South Wales Poisons Information Centre, The Children's Hospital at Westmead, Westmead, Australia.
Brown JA; New South Wales Poisons Information Centre, The Children's Hospital at Westmead, Westmead, Australia.
Chan BS; Faculty of Medicine, University of New South Wales, Sydney, Australia.; Clinical Toxicology Unit, Prince of Wales Hospital, Randwick, Australia.
Pokaż więcej
Źródło:
Clinical toxicology (Philadelphia, Pa.) [Clin Toxicol (Phila)] 2021 Jun; Vol. 59 (6), pp. 464-471. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji:
Journal Article
MeSH Terms:
Angiotensin Receptor Antagonists/*pharmacology
Angiotensin-Converting Enzyme Inhibitors/*pharmacology
Calcium Channel Blockers/*poisoning
Dihydropyridines/*poisoning
Hemodynamics/*drug effects
Adult ; Aged ; Blood Pressure/drug effects ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Angiotensin-Inhibiting Drugs Do Not Impact Disease Activity in Patients with Rheumatoid Arthritis: A Retrospective Cross-Sectional Study.
Autorzy:
Sluijsmans DMCF; Department of Rheumatology, Sint Maartenskliniek, Hengstdal nr 3, 6574 NA Ubbergen, The Netherlands.; Department of Pharmacy, Sint Maartenskliniek, 6574 NA Ubbergen, The Netherlands.
Rohrich DC; Department of Rheumatology, Sint Maartenskliniek, Hengstdal nr 3, 6574 NA Ubbergen, The Netherlands.
Popa CD; Department of Rheumatology, Sint Maartenskliniek, Hengstdal nr 3, 6574 NA Ubbergen, The Netherlands.; Department of Rheumatology, Radboud University Nijmegen Medical Centre, 6525 GA Nijmegen, The Netherlands.
van den Bemt BJF; Department of Pharmacy, Sint Maartenskliniek, 6574 NA Ubbergen, The Netherlands.; Department of Pharmacy, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2021 May 05; Vol. 10 (9). Date of Electronic Publication: 2021 May 05.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Higher comorbidities and early death in hospitalized African-American patients with Covid-19.
Autorzy:
Gupta R; SUNY Downstate Medical Center, Departments of Pathology and Cell Biology, 450 Clarkson Ave. MSC #37, Brooklyn, NY, 11203, USA. .
Agrawal R; Department of Pathology, SUNY Downstate Medical Center, Brooklyn, USA.
Bukhari Z; Department of Pathology, SUNY Downstate Medical Center, Brooklyn, USA.
Jabbar A; Department of Pathology, SUNY Downstate Medical Center, Brooklyn, USA.
Wang D; Department of Pathology, SUNY Downstate Medical Center, Brooklyn, USA.
Diks J; Department of Pathology, SUNY Downstate Medical Center, Brooklyn, USA.
Alshal M; Department of Pathology, SUNY Downstate Medical Center, Brooklyn, USA.
Emechebe DY; Department of Pathology, SUNY Downstate Medical Center, Brooklyn, USA.
Brunicardi FC; Department of Surgery, SUNY Downstate Medical Center, Brooklyn, USA.
Lazar JM; Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, USA.
Chamberlain R; Department of Anesthesiology, SUNY Downstate Medical Center, Brooklyn, USA.
Burza A; Division of Pulmonary Medicine and Critical Care, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, USA.
Haseeb MA; SUNY Downstate Medical Center, Departments of Pathology and Cell Biology, 450 Clarkson Ave. MSC #37, Brooklyn, NY, 11203, USA.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2021 Jan 18; Vol. 21 (1), pp. 78. Date of Electronic Publication: 2021 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
Black or African American/*statistics & numerical data
COVID-19/*ethnology
COVID-19/*mortality
Adult ; Aged ; Aged, 80 and over ; Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors ; COVID-19/blood ; COVID-19/therapy ; Comorbidity ; Diabetes Mellitus/epidemiology ; Female ; Hospital Mortality/ethnology ; Hospitalization ; Humans ; Hypertension/epidemiology ; Male ; Middle Aged ; New York City/epidemiology ; Pandemics/statistics & numerical data ; Respiration, Artificial/mortality ; Retrospective Studies ; SARS-CoV-2
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of Recent Use of Renin-Angiotensin System Inhibitors on Mortality of Patients With Coronavirus Disease 2019.
Autorzy:
Bae S; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim JH; Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim YJ; Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Lim JS; Clinical Research Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Yun SC; Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim YH; Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Lee SO; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim SH; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2020 Oct 27; Vol. 7 (11), pp. ofaa519. Date of Electronic Publication: 2020 Oct 27 (Print Publication: 2020).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Risk factors for severity of COVID-19 in chronic dialysis patients from a multicentre French cohort.
Autorzy:
Lano G; Department of Nephrology and Renal Transplantation, Assistance Publique-Hôpitaux de Marseille, La Conception Hospital, Marseille, France.; Aix-Marseille University, C2VN, INSERM 1263, INRAe 1260, Marseille, France.
Braconnier A; Department of Nephrology and Renal Transplantation, Maison Blanche Hospital, University Hospital of Reims, Reims, France.
Bataille S; Aix-Marseille University, C2VN, INSERM 1263, INRAe 1260, Marseille, France.; Elsan, Phocean Institute of Nephrology, Clinique Bouchard, Marseille, France.
Cavaille G; DIAVERUM, Saint Joseph Hospital, Marseille, France.
Moussi-Frances J; DIAVERUM, Saint Joseph Hospital, Marseille, France.
Gondouin B; Department of Nephrology and Renal Transplantation, Assistance Publique-Hôpitaux de Marseille, La Conception Hospital, Marseille, France.; Association des Dialysés Provence et Corse (ADPC), Marseille, France.
Bindi P; Department of Nephrology, Verdun Hospital, Verdun, France.
Nakhla M; Department of Nephrology, Laon Hospital, Laon, France.
Mansour J; Department of Nephrology, Soissons Hospital, Soissons, France.
Halin P; Department of Nephrology, Charleville-Mézières Hospital, Charleville-Mézières, France.
Levy B; Department of Nephrology, Troyes Hospital, Troyes, France.
Canivet E; Association Régionale pour la Promotion de la Dialyse à Domicile (ARPDD), Reims, France.
Gaha K; Department of Nephrology and Renal Transplantation, Maison Blanche Hospital, University Hospital of Reims, Reims, France.
Kazes I; Department of Nephrology and Renal Transplantation, Maison Blanche Hospital, University Hospital of Reims, Reims, France.
Noel N; Department of Nephrology and Renal Transplantation, Maison Blanche Hospital, University Hospital of Reims, Reims, France.
Wynckel A; Department of Nephrology and Renal Transplantation, Maison Blanche Hospital, University Hospital of Reims, Reims, France.
Debrumetz A; Department of Nephrology and Renal Transplantation, Maison Blanche Hospital, University Hospital of Reims, Reims, France.
Jourde-Chiche N; Department of Nephrology and Renal Transplantation, Assistance Publique-Hôpitaux de Marseille, La Conception Hospital, Marseille, France.; Aix-Marseille University, C2VN, INSERM 1263, INRAe 1260, Marseille, France.
Moal V; Department of Nephrology and Renal Transplantation, Assistance Publique-Hôpitaux de Marseille, La Conception Hospital, Marseille, France.
Vial R; Department of Nephrology and Renal Transplantation, Assistance Publique-Hôpitaux de Marseille, La Conception Hospital, Marseille, France.
Scarfoglière V; Department of Nephrology and Renal Transplantation, Assistance Publique-Hôpitaux de Marseille, La Conception Hospital, Marseille, France.
Bobot M; Department of Nephrology and Renal Transplantation, Assistance Publique-Hôpitaux de Marseille, La Conception Hospital, Marseille, France.; Aix-Marseille University, C2VN, INSERM 1263, INRAe 1260, Marseille, France.
Gully M; Department of Nephrology and Renal Transplantation, Assistance Publique-Hôpitaux de Marseille, La Conception Hospital, Marseille, France.
Legris T; Department of Nephrology and Renal Transplantation, Assistance Publique-Hôpitaux de Marseille, La Conception Hospital, Marseille, France.
Pelletier M; Department of Nephrology and Renal Transplantation, Assistance Publique-Hôpitaux de Marseille, La Conception Hospital, Marseille, France.
Sallee M; Department of Nephrology and Renal Transplantation, Assistance Publique-Hôpitaux de Marseille, La Conception Hospital, Marseille, France.; Aix-Marseille University, C2VN, INSERM 1263, INRAe 1260, Marseille, France.
Burtey S; Department of Nephrology and Renal Transplantation, Assistance Publique-Hôpitaux de Marseille, La Conception Hospital, Marseille, France.; Aix-Marseille University, C2VN, INSERM 1263, INRAe 1260, Marseille, France.
Brunet P; Department of Nephrology and Renal Transplantation, Assistance Publique-Hôpitaux de Marseille, La Conception Hospital, Marseille, France.; Aix-Marseille University, C2VN, INSERM 1263, INRAe 1260, Marseille, France.
Robert T; Department of Nephrology and Renal Transplantation, Assistance Publique-Hôpitaux de Marseille, La Conception Hospital, Marseille, France.
Rieu P; Department of Nephrology and Renal Transplantation, Maison Blanche Hospital, University Hospital of Reims, Reims, France.; Laboratory of Nephrology, UMR CNRS URCA 7369 (Matrice Extracellulaire et Dynamique Cellulaire, MEDyC), Reims, France.
Pokaż więcej
Źródło:
Clinical kidney journal [Clin Kidney J] 2020 Oct 21; Vol. 13 (5), pp. 878-888. Date of Electronic Publication: 2020 Oct 21 (Print Publication: 2020).
Typ publikacji:
Journal Article; Comment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The renin-angiotensin system in cutaneous hypertrophic scar and keloid formation.
Autorzy:
Hedayatyanfard K; Evidence-Based Phytotherapy and Complementary Medicine Research Center, Alborz University of Medical Sciences, Karaj, Iran.; Cardiovascular Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Haddadi NS; Cardiovascular Research Center, Alborz University of Medical Sciences, Karaj, Iran.; Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Ziai SA; Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences.
Karim H; Cardiovascular Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Niazi F; Department of Plastic and Reconstructive Surgery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Steckelings UM; Institute for Molecular Medicine, Department of Cardiovascular and Renal Research, University of Southern Denmark, Odense, Denmark.
Habibi B; Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences.
Modarressi A; Department of Plastic, Reconstructive and Aesthetic Surgery, Geneva University Hospitals, Faculty of Medicine, University of Geneva, Switzerland.
Dehpour AR; Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło:
Experimental dermatology [Exp Dermatol] 2020 Sep; Vol. 29 (9), pp. 902-909. Date of Electronic Publication: 2020 Aug 05.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Renin-Angiotensin System*
Cicatrix, Hypertrophic/*etiology
Keloid/*etiology
Skin/*metabolism
Angiotensin Receptor Antagonists/administration & dosage ; Angiotensin-Converting Enzyme Inhibitors/administration & dosage ; Animals ; Cicatrix, Hypertrophic/drug therapy ; Fibrosis ; Humans ; Keloid/drug therapy ; Skin/pathology ; Wound Healing
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of diabetes, angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker use, and statin use on presentation and outcomes in patients with giant cell arteritis.
Autorzy:
Ma J; Toronto Western Hospital, University of Toronto, Toronto, ON, Canada.
Khalidi N; Division of Rheumatology, St Joseph's Healthcare, McMaster University, Hamilton, Canada.
Wierzbicki O; Division of Rheumatology, St Joseph's Healthcare, McMaster University, Hamilton, Canada.
Alqutami A; Vasculitis Clinic, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.; Division of Rheumatology, King Fahad Hospital, Jeddah, Saudi Arabia.
Ioannidis G; Division of Rheumatology, St Joseph's Healthcare, McMaster University, Hamilton, Canada.
Pagnoux C; Vasculitis Clinic, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.
Pokaż więcej
Źródło:
International journal of rheumatic diseases [Int J Rheum Dis] 2020 Aug; Vol. 23 (9), pp. 1233-1239. Date of Electronic Publication: 2020 Aug 10.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Diabetes Mellitus*/diagnosis
Angiotensin Receptor Antagonists/*therapeutic use
Angiotensin-Converting Enzyme Inhibitors/*therapeutic use
Giant Cell Arteritis/*drug therapy
Glucocorticoids/*therapeutic use
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use
Aged ; Angiotensin Receptor Antagonists/adverse effects ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Female ; Giant Cell Arteritis/complications ; Giant Cell Arteritis/diagnosis ; Glucocorticoids/adverse effects ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects ; Male ; Middle Aged ; Ontario ; Progression-Free Survival ; Recurrence ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 43

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies